Page last updated: 2024-10-30

mesalamine and Anal Fistula

mesalamine has been researched along with Anal Fistula in 5 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"The recurrence rate of Crohn's disease after surgery is very high."2.40[Therapy of Crohn disease in internal medicine: postoperative recurrence and fistulas]. ( Blum, HE; Volk-Zeiher, BA, 1998)
"The difference in 6 months recurrence rates of subjects receiving or not receiving mesalazine was the primary outcome measure."1.72The role of mesalazine co-treatment in the prevention of recurrence in subjects with subclinical inflammatory bowel disease and perianal fistula who are scheduled for surgical intervention. ( Akturk, R; Serinsöz, S, 2022)
"Appropriate treatment of perianal fistulas in Crohn's disease (CD) involves accurate anatomic evaluation."1.38Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy. ( Assulin, Y; Beer-Gabel, M; Chowers, Y; Lahat, A, 2012)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Akturk, R1
Serinsöz, S1
Xie, X1
Liu, L1
Zheng, Z1
Han, Z1
Zhi, M1
Kaplan, DL1
Li, G1
Wang, X1
Kaye, TL1
O'Connor, A1
Burke, D1
Tolan, DJ1
Lahat, A1
Assulin, Y1
Beer-Gabel, M1
Chowers, Y1
Volk-Zeiher, BA1
Blum, HE1

Reviews

2 reviews available for mesalamine and Anal Fistula

ArticleYear
A young woman with recurrent perianal sepsis.
    BMJ (Clinical research ed.), 2015, Apr-23, Volume: 350

    Topics: Abscess; Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drainage; Female; Humans; Ma

2015
[Therapy of Crohn disease in internal medicine: postoperative recurrence and fistulas].
    Praxis, 1998, Nov-26, Volume: 87, Issue:48

    Topics: Combined Modality Therapy; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mesalamine

1998

Other Studies

3 other studies available for mesalamine and Anal Fistula

ArticleYear
The role of mesalazine co-treatment in the prevention of recurrence in subjects with subclinical inflammatory bowel disease and perianal fistula who are scheduled for surgical intervention.
    Annali italiani di chirurgia, 2022, Volume: 93

    Topics: Colonoscopy; Humans; Inflammatory Bowel Diseases; Mesalamine; Rectal Fistula; Recurrence; Retrospect

2022
Silk Fibroin-Based Fibrous Anal Fistula Plug with Drug Delivery Function.
    Macromolecular bioscience, 2018, Volume: 18, Issue:4

    Topics: Cell Line; Cell Proliferation; Crohn Disease; Curcumin; Drug Delivery Systems; Drug Liberation; Fibr

2018
Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:3

    Topics: Abscess; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory

2012